•  

Toronto Innovation Acceleration Partners – TIAP – specializes in  venture building of

early-stage health science technologies emerging from our members.

TIAP was formerly MaRS Innovation

Our Members
TIAP’s portfolio draws from three universities, nine teaching hospitals and two research institutes. Learn more about our members.
Learn More
Work With Us
Through our member-exclusive funding programs and services, TIAP works with founders to bring their health science technologies to market faster.
Learn More
Recent News

FedDev Ontario Funding Support – Portfolio Investments

On October 9, 2020, the Honourable Mélanie Joly, Minister of Economic Development and Official Languages and Minister responsible for the Federal Economic Development Agency for Southern Ontario (FedDev Ontario) announced a FedDev Ontario contribution …

Notch Therapeutics Raises $85M Series A Financing

TIAP portfolio company Notch Therapeutics has announced one of the largest Series A financing rounds in the history of Canadian biotech. We are proud to say that we were there from the start in …

Webinar February 24, 2021: Adventures in Drug Hunting – Identify and Advance Your Drug-Like Molecule

On February 24, 2021 TIAP hosted a LAB150 webinar entitled Adventures in Drug Hunting: Identify and Advance Your Drug-Like Molecule. 
Click to listen to a recording of the webinar:
https://zoom.us/rec/share/VllBSf8Jw4_O2mz70LGTuYQwTJb1MZ5ksnYaiY6YrsPRZI8Xfsx0B9yNRl-Q98gc._i9OthG2tcQC58eP. Access Passcode: VF2k!vXj

Here is the full description of …

TIAP & Amgen Co-funds transformative projects to support new venture development

December 8, 2020
TIAP announces co-funding of transformative projects with Amgen to support new venture development

Toronto Innovation Acceleration Partners (TIAP) is excited to announce co-investments made with a key strategic partner, Amgen Inc., into three …

TIAP shifted my perspective from BlueDot's research to its potential as a global business. They worked with me to incorporate the company, develop a business plan and model suitable for a social enterprise, and hire key talent, while supporting me through BlueDot’s early stages of growth and development.
Kamran Khan, MD, MPH
Founder / BlueDot
TIAP understood the value of my invention and saw its potential when others didn’t (they’re starting to now!). I’m grateful for the investment and mentoring I received through the UTEST program.
James Colliander, PhD
Co-Founder / Crowdmark
The UTEST program and TIAP have been fantastic for TrendMD; we would not be where we are today without them. Both from a strategic and financial perspective, UTEST definitely served as the initial spark that was crucial for getting us off the ground.
Paul Kudlow, MD
Founder / TrendMD
TIAP’s unique ecosystem allows innovators and researchers to keep the high impact of their innovation while enabling it with frameworks for commercialization. Their dedicated expert team allowed us to launch, structure and scale our company both in Canada and in the rest of the world while allowing us to maintain our research and academic mandates.
Hossein Rahnama, PhD
Founder / Flybits
TIAP was a vital partner as we refined our technology, our business model and our go-to-market strategy. Without their support, and the support of UTEST, we would not be in the position we are today.
Craig Boutilier, PhD
Co-Founder / Granata Decision Systems